Symptomatic burdens are greater in female patients with asthma maintaining exacerbation-free and OCS-free conditions under biologic treatments compared to male counterparts. This sex difference may cause a lower rate of CR in females particularly when CR requires almost complete symptomatic resolution.
Hayashi et al. (Thu,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: